Phase iv implementation studies: The forgotten finale to the complex intervention methodology framework

Annals of the American Thoracic Society

Volumn 11, Issue SUPPL. 2, 2014, Pages

  Pinnock, Hilary ^a   Epiphaniou, Eleni ^b   Taylor, Stephanie J C ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Complex interventions; Phase IV implementation studies; Reporting standards

Indexed keywords

CHECKLIST; CLINICAL PRACTICE; CONFERENCE PAPER; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; SYSTEMATIC REVIEW; TELECONSULTATION;

CHECKLIST; CLINICAL TRIALS, PHASE IV AS TOPIC; HUMANS; QUALITY IMPROVEMENT; RESEARCH REPORT;

EID: 84898757891     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201308-259RM     Document Type: Conference Paper

References (39)

1. Chalkidou K, Anderson G. Comparative effectiveness research: international experiences and implications for the United States [Internet] [updated 2009 Jul; accessed 2013 Aug 4]. Available from: https://www. academyhealth.org
2. Australian Government. Pharmaceutical Benefits Advisory Committee (PBAC) [Internet] [updated 2013 Aug 4; accessed 2013 Aug 4]. Available from: http://www.pbs.gov.au/info/industry/listing/participants/pbac
3. Canadian Agency for Drugs and Technologies in Health. Health technology assessments [Internet] [updated 2013; accessed 2013 Aug 4]. Available from: http://www.cadth.ca/en/products/health-technology-assessment/ health-technology-assessments
4. National Institute for Health and Clinical Excellence [Internet] [updated 2013; accessed 2013 Aug 4]. Available from: http://www.nice.org.uk/
5. Campbell M, Fitzpatrick R, Haines A, Kinmonth A-L, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-696.
6. Moullec G, Gour-Provencal G, Bacon SL, Campbell TS, Lavoie KL. Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model. Respir Med 2012;106:1211-1225.
7. Eccles M, Grimshaw J, Campbell M, Ramsay C. Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care 2003;12:47-52. (Pubitemid 36241256)
8. Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 [Internet]. The Cochrane Collaboration; 2011 [updated 2011 Mar; accessed 2013 July 28]. Available from: http://www.cochrane- handbook.org
9. Grading of Recommendations Assessment, Development and Evaluation (GRADE). Grading the quality of evidence and the strength of recommendations [Internet] [updated 2011 Nov; accessed 2013 Jul 28]. Available from: http://www.gradeworkinggroup.org/index.htm
10. Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developer's handbook [Internet]. Edinburgh: SIGN; 2011 [updated 2011 Nov; accessed 2013 Jul 28]. Available from: http://www.sign.ac.uk/guidelines/ fulltext/50
11. The AGREE Research Trust. Appraisal of guidelines for research and evaluation II [Internet] [updated 2009 May; accessed 2013 Jul 28]. Available from: http://www.agreetrust.org
12. National Institute for Health and Clinical Excellence. Clinical guideline development methods: the guidelines manual 2012 [Internet]. Birmingham, UK: NICE; 2012 [updated 2012 Nov 30; accessed 2013 Jul 28]. Available from: http://publications.nice.org.uk/the-guidelines-manual-pmg6#nice-guidance
13. Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RFT, Juniper EF, Ayres JG, Kemp L, Blyth A, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 2011;364:1695-1707.
14. Medical Research Council. A framework for the development and evaluation of RCTs for complex interventions to improve health [Internet]. London: MRC; 2000 [updated 2000 Apr 1; accessed 2013 Jul 28]. Available from: http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC003372
15. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance [Internet] London: MRC; 2008 [updated 2008 Sep 29; accessed 2013 Jul 28]. Available from: http://www.mrc.ac.uk/complexinterventionsguidance
16. Web of Knowledge. Web of Knowledge Service for UK Education [Internet] [updated 2013 Aug 4; accessed 2013 Aug 4]. Available from: http://wok.mimas.ac. uk/
17. Eldridge S, Kerry S. A practical guide to cluster randomised trials in health research. Chichester: Wiley; 2012.
18. Woolf SH, Johnson RE. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med 2005;3:545-552. (Pubitemid 43154841)
19. Meredith LS, Mendel P, Pearson M, Wu SY, Joyce G, Straus JB, Ryan G, Keeler E, Unützer J. Implementation and maintenance of quality improvement for treating depression in primary care. Psychiatr Serv 2006;57:48-55. (Pubitemid 43053836)
20. Glasgow RE, Lichtenstein E,Marcus AC. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to- effectiveness transition. Am J Public Health 2003;93:1261-1267. (Pubitemid 38480188)
21. Kelly JA, Spielberg F, McAuliffe TL. Defining, designing, implementing, and evaluating phase 4 HIV prevention effectiveness trials for vulnerable populations. J Acquir Immune Defic Syndr 2008;47:S28-S33. (Pubitemid 351323598)
22. Narayan KMV, Gregg EW, Engelgau MM, Moore B, Thompson TJ, Williamson DF, Vinicor F. Translation research for chronic disease: the case of diabetes. Diabetes Care 2000;23:1794-1798.
23. Pinnock H, Bawden R, Proctor S, Wolfe S, Scullion J, Price D, Sheikh A. Accessibility, acceptability and effectiveness of telephone reviews for asthma in primary care: randomised controlled trial. BMJ 2003;326:477-479. (Pubitemid 36269630)
24. Pinnock H, Adlem L, Gaskin S, Harris J, Snellgrove C, Sheikh A. Accessibility, clinical effectiveness, and practice costs of providing a telephone option for routine asthma reviews: phase IV controlled implementation study. Br J Gen Pract 2007;57:714-722. (Pubitemid 47423017)
25. Newhouse R, Bobay K, Dykes PC, Stevens KR, Titler M. Methodology issues in implementation science. Med Care 2013;51:S32-S40.
26. Rycroft-Malone J, Burton CR. Is it time for standards for reporting on research about implementation? Worldviews Evid Based Nurs 2011;8:189-190.
27. Taylor S, Pinnock H, Sheikh A, Griffiths C, Greenhalgh T, Ribchester J. A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions [Internet] [updated 2012 Apr 1; accessed 2013 Aug 4]. Available from: http://www.netscc.ac.uk/hsdr/projdetails.php?ref=11- 1014-04
28. Epiphaniou E, Parke HL, Pearce G, Taylor SJC, Pinnock H. Implementing asthma self-management - a systematic review of MRC phase IV implementation studies. Selected abstracts from the 3rd IPCRG International Scientific Meeting, Uppsala, May 2013. Prim Care Respir J 2013;22:A1-A18. DOI: http://dx.doi.org/ 10.4104/pcrj.2013.00056
29. Ogrinc G, Mooney SE, Estrada C, Foster T, Goldmann D, Hall LW, Huizinga MM, Liu SK, Mills P, Neily J, et al. The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care 2008;17:i13-i32.
30. Hawe P, Shiell A, Riley T. Complex interventions: how "out of control" can a randomised controlled trial be? BMJ 2004;328:1561-1563. (Pubitemid 38850320)
31. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010;8:18.
32. Altman DG, Simera I, Hoey J, Moher D, Schulz K. EQUATOR: reporting guidelines for health research. Lancet 2008;371:1149-1150. (Pubitemid 351467721)
33. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
34. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-349.
35. Davidoff F, Batalden P, Stevens D, Ogrinc G, Mooney SE; SQUIRE Development Group. Publication guidelines for quality improvement in health care: evolution of the SQUIRE project. Qual Saf Health Care 2008;17:i3-i9.
36. Des Jarlais DC, Lyles C, Crepaz N; TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004;94:361-366. (Pubitemid 38269486)
37. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D; CONSORT group; Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.
38. May C. A rational model for assessing and evaluating complex interventions in health care. BMC Health Serv Res 2006;6:86.
39. French SD, Green SE, O'Connor DA, McKenzie JE, Francis JJ, Michie S, Buchbinder R, Schattner P, Spike N, Grimshaw JM. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implement Sci 2012;7:38.